Himension Capital (Singapore)’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.77M Sell
25,218
-10,120
-29% -$524K 0.11% 70
2026
Q1
$1.8M Sell
35,338
-22,390
-39% -$1.04M 0.14% 60
2025
Q4
$1.7M Sell
57,728
-8,937
-13% -$243K 0.11% 53
2025
Q3
$1.72M Buy
66,665
+35,193
+112% +$982K 0.11% 55
2025
Q2
$868K Sell
31,472
-2,290
-7% -$60.3K 0.07% 51
2025
Q1
$957K Buy
33,762
+2,164
+7% +$76.8K 0.08% 54
2024
Q4
$1.31M Buy
31,598
+21,102
+201% +$1.01M 0.09% 38
2024
Q3
$701K Buy
+10,496
New +$964K 0.05% 32
2023
Q4
Sell
-2,553
Closed -$264K 77
2023
Q3
$264K Buy
+2,553
New +$285K 0.03% 69

Other funds holding MRNA

Himension Capital (Singapore)'s MRNA Position: Q2 2026 in Review

Himension Capital (Singapore) reduced its Moderna (MRNA) stake by 29% in Q2 2026, selling an estimated $524K and leaving 25,218 shares worth $1.77M. The position accounts for 0.11% of the portfolio, ranked #70.

Himension Capital (Singapore) first reported a position in MRNA in Q3 2023 and has held it in 9 quarters since. The position peaked at $1.8M in Q1 2026. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Himension Capital (Singapore) held 25,218 shares of Moderna worth $1.77M as of Q2 2026.
  • Himension Capital (Singapore) sold 10,120 Moderna shares in Q2 2026, an estimated $524K.
  • Moderna made up 0.11% of Himension Capital (Singapore)'s portfolio in Q2 2026, its #70 holding.
  • Himension Capital (Singapore) first reported a position in Moderna in Q3 2023 and has held it in 9 quarters since.
  • Himension Capital (Singapore)'s Moderna position peaked at $1.8M in Q1 2026.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Himension Capital (Singapore)'s 13F filing for Q2 2026, filed 13 Aug 2026.